168 related articles for article (PubMed ID: 2578300)
1. Non-seminomatous germ cell testicular tumours: residual masses after chemotherapy.
Levitt MD; Reynolds PM; Sheiner HJ; Byrne MJ
Br J Surg; 1985 Jan; 72(1):19-22. PubMed ID: 2578300
[TBL] [Abstract][Full Text] [Related]
2. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
3. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
4. Non-seminomatous testicular germ cell tumours. Preliminary analysis of ongoing trials in the DATECA Study.
Rørth M; von der Maase H; Sandberg Nielsen E; Schultz HP; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):295-304. PubMed ID: 6208750
[TBL] [Abstract][Full Text] [Related]
5. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours.
Napier MP; Naraghi A; Christmas TJ; Rustin GJ
Br J Cancer; 2000 Nov; 83(10):1274-80. PubMed ID: 11044349
[TBL] [Abstract][Full Text] [Related]
7. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
Horvath LG; McCaughan BC; Stockle M; Boyer MJ
Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
[TBL] [Abstract][Full Text] [Related]
8. Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours.
Harding MJ; Brown IL; MacPherson SG; Turner MA; Kaye SB
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1689-94. PubMed ID: 2561098
[TBL] [Abstract][Full Text] [Related]
9. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
10. Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
McKendrick JJ; Mead GM; Cowlishaw D
Clin Oncol (R Coll Radiol); 2003 May; 15(3):128-31. PubMed ID: 12801050
[No Abstract] [Full Text] [Related]
11. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
[TBL] [Abstract][Full Text] [Related]
12. [Testis germ cell tumours: which chemotherapy, for which patients?].
Fléchon A; Droz JP
Ann Urol (Paris); 2007 Apr; 41(2):56-67. PubMed ID: 17486913
[TBL] [Abstract][Full Text] [Related]
13. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
[TBL] [Abstract][Full Text] [Related]
14. [A case of bilateral germ cell tumor of the testis].
Saito M; Kondo A; Kinjo T
Hinyokika Kiyo; 1989 Nov; 35(11):1961-4. PubMed ID: 2482675
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
16. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
17. Management of advanced metastatic germ cell tumours.
Daugaard G; Hansen HH; Rørth M
Int J Androl; 1987 Feb; 10(1):319-24. PubMed ID: 2438225
[TBL] [Abstract][Full Text] [Related]
18. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
19. Vascular toxicity following vinblastine, bleomycin, and cisplatin therapy for germ cell tumours.
Samuels BL; Vogelzang NJ; Kennedy BJ
Int J Androl; 1987 Feb; 10(1):363-9. PubMed ID: 2438227
[TBL] [Abstract][Full Text] [Related]
20. [Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
Takizawa A; Miura T; Fujinami K; Osada Y
Hinyokika Kiyo; 2005 Apr; 51(4):247-51. PubMed ID: 15912783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
